These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32168743)
21. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting]. Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941 [TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. He M; Zhao Z; Yin L; Tang C; Yin C Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer. Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589 [TBL] [Abstract][Full Text] [Related]
24. A nanoformulation of cisplatin with arabinoxylan having enhanced activity against hepatocellular carcinoma through upregulation of apoptotic and necroptotic pathways. Rana S; Shahid S; Iqbal MS; Arshad A; Khan D Heliyon; 2024 May; 10(10):e31057. PubMed ID: 38774332 [TBL] [Abstract][Full Text] [Related]
25. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells. Kuo YC; Chung CY Colloids Surf B Biointerfaces; 2012 Mar; 91():242-9. PubMed ID: 22137614 [TBL] [Abstract][Full Text] [Related]
26. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles. Jin X; Huang A; Ping Q; Cao F; Su Z Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067 [TBL] [Abstract][Full Text] [Related]
27. Cisplatin-loaded polymeric complex micelles with a modulated drug/copolymer ratio for improved in vivo performance. Chen Q; Luo L; Xue Y; Han J; Liu Y; Zhang Y; Yin T; Wang L; Cun D; Gou J; He H; Tang X Acta Biomater; 2019 Jul; 92():205-218. PubMed ID: 31071475 [TBL] [Abstract][Full Text] [Related]
28. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin. He W; Jiang X; Zhang ZR J Pharm Sci; 2008 Jun; 97(6):2250-9. PubMed ID: 17853430 [TBL] [Abstract][Full Text] [Related]
29. [Preparation and in vitro release characteristics of vincristine sulphate loaded poly (butylcyanoacrylate) nanoparticles]. Tan R; Liu Y; Feng N; Zhao J Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1431-5. PubMed ID: 22779171 [TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin. Tian J; Pang X; Yu K; Liu L; Zhou J Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008 [TBL] [Abstract][Full Text] [Related]
31. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles. Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943 [TBL] [Abstract][Full Text] [Related]
32. Anticancer Effect of Cisplatin-Loaded Poly (Butylcyanoacrylate) Nanoparticles on A172 Brain Cancer Cells Line. Chiani M; Toofani Milani A; Nemati M; Rezaeidian J; Ehsanbakhsh H; Ahmadi Z; Mazloomi E; Sadeghi V; Akbarzadeh Khiyavi A Asian Pac J Cancer Prev; 2019 Jan; 20(1):303-309. PubMed ID: 30678454 [TBL] [Abstract][Full Text] [Related]
33. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats. Bagad M; Khan ZA Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668 [TBL] [Abstract][Full Text] [Related]
34. Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs. Lin MH; Chung CY; Chen KT; Yeh JC; Lee TH; Lee MH; Lee IN; Huang WC; Yang JT Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621332 [TBL] [Abstract][Full Text] [Related]
35. Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems. Gao S; Xu Y; Asghar S; Chen M; Zou L; Eltayeb S; Huo M; Ping Q; Xiao Y J Drug Target; 2015; 23(6):481-96. PubMed ID: 25738991 [TBL] [Abstract][Full Text] [Related]
36. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells. Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189 [TBL] [Abstract][Full Text] [Related]
37. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel N-vinylpyrrolidone/acrylic acid nanoparticles as drug delivery carriers of cisplatin to cancer cells. Pornpitchanarong C; Rojanarata T; Opanasopit P; Ngawhirunpat T; Patrojanasophon P Colloids Surf B Biointerfaces; 2020 Jan; 185():110566. PubMed ID: 31655265 [TBL] [Abstract][Full Text] [Related]
39. Tamoxifen-loaded poly(L-lactide) nanoparticles: Development, characterization and in vitro evaluation of cytotoxicity. Altmeyer C; Karam TK; Khalil NM; Mainardes RM Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():135-142. PubMed ID: 26706516 [TBL] [Abstract][Full Text] [Related]
40. Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models. Beck P; Kreuter J; Reszka R; Fichtner I J Microencapsul; 1993; 10(1):101-14. PubMed ID: 8445503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]